Newswise — The Cancer Research Institute (CRI) will host its 22nd Annual International Cancer Immunotherapy Symposium October 6-8, 2014, at The Grand Hyatt in New York City. Attracting more than 560 clinicians, laboratory scientists, postdoctoral fellows, and graduate students from medical research universities and clinics around the world, the symposium will feature plenary presentations from leaders in immunology and cancer immunotherapy, a poster session, and numerous networking opportunities.
This year’s CRI symposium, entitled “Cancer Immunotherapy: Out of the Gate,” will harness the excitement and enthusiasm generated by recent clinical successes to explore new and emerging areas of basic, translational, and clinical research. Topics such as the use of genomic methods to catalog cancer heterogeneity, mechanistic studies of checkpoint blockage antibodies, new views on immunosurveillance and immunoregulation, and emerging therapies that are altering the landscape of cancer treatment will be discussed.
New to the meeting this year, CRI will host a special Cancer Immunotherapy Consortium (CIC) satellite meeting on October 5 entitled “Development of Surrogate Endpoints for Cancer Immunotherapy Trials.” The meeting will consist of a full day of presentations and panel discussions addressing the key rationale, challenges, and solutions surrounding the development of surrogate endpoints for cancer immunotherapy. This meeting will represent the culmination of a CIC-led community-wide effort that brings together the major stakeholders in the field, including experts from industry, academia, and regulatory bodies as well as patients. The output of the meeting will be a consensus-driven road map for the efficient regulatory approval of future immunotherapies.
Cancer Immunotherapy 2014 Planning Committee James P. Allison, The University of Texas MD Anderson Cancer Center Glenn Dranoff, Dana-Farber Cancer Institute Carl F. Nathan, Weill Cornell Medical College Ellen Puré, University of Pennsylvania School of Veterinary Medicine Robert D. Schreiber, Washington University School of Medicine Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center
The following sponsors have provided generous support for the symposium through educational grants:
Diamond Sponsor: Merck Platinum Sponsors: Bristol-Myers Squibb, Genentech, Regeneron
To register for the meeting, visit http://bit.ly/crisymp2014.
RSS